- Home
- TIGR vs ACHV Comparison
TIGR vs ACHV Comparison
Compare TIGR & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIGR | ACHV |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 748.2M | 726.5M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TIGR | ACHV |
|---|---|---|
| Price | $4.05 | $6.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | $7.71 | ★ $14.15 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 12-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.26 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.00 | $2.62 |
| 52 Week High | $11.35 | $8.64 |
Technical Indicators
Market Signals| Indicator | TIGR | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 33.57 |
| Support Level | N/A | $5.84 |
| Resistance Level | $5.05 | $6.64 |
| Average True Range (ATR) | 0.17 | 0.38 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 0.98 | 12.14 |
Price Performance
Historical ComparisonAbout TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.